New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

The most active, highest-spending startup investors are leading a lot of large new rounds lately. When it comes to exits, ...

The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. . Shareholders who purchased shares of ...

Class Action, Consumer Services, GlobeNewswire, Law & Legal Issues | NEW YORK, March 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law ...

In truth, BioAge was forced to discontinue the STRIDES Phase 2 trial after several subjects exhibited elevated liver enzyme levels, indicating potential organ damage. Consequently, the Company ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Market ...

WHAT'S NEXT? If you suffered a loss in BioAge during the relevant time frame, you have until March 10, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any ...

The law firm of Kirby McInerney LLP notifies investors of the approaching March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. pursuant and/or traceable to the registration statement for BioAge's initial public offering ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge’s registration statem ...

RICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for ...

BIOA Investors with Losses Encouraged to Contact the Firm Before Mar. 10th, 2025 DeadlineSAN FRANCISCO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- B ...